QT Vascular said today that it won an investigational device exemption from the FDA for a pivotal study of its Chocolate Touch drug-coated balloon. The device won the CE Mark for treating peripheral artery disease in September 2015 and in July it won approval for treating coronary artery disease. The Singapore-based company is slated to […]
QT Vascular
Appeals court tosses $20m AngioScore win over TriReme Medical
A federal appeals court yesterday tossed AngioScore‘s $20 million win over TriReme Medical and a pair of related companies, ruling that the case never should have made it to the federal level. Just more than a year ago, Judge Yvonne Gonzalez Rogers of the U.S. District Court for Northern California ruled that AngioScore founder Eitan Konstantino violated his duties to AngioScore when […]
QT Vascular wins CE Mark for Chocolate Heart DCB
QT Vascular said today that it won CE Mark approval in the European Union for its Chocolate Heart drug-coated balloon for treating coronary artery disease. The Chocolate Heart device is a paclitaxel-coated version of the Chocolate balloon that won FDA approval back in June 2014, the Singapore-based company said. “We are delighted with the CE […]
Appeals court reverses TriReme patent loss to AngioScore
CORRECTED July 22, 2016. This article originally transposed the patent infringement lawsuit filed by TriReme against AngioScore for a breach-of-contract lawsuit filed by AngioScore. A federal appeals court today reversed a lower court’s patent infringement ruling that went against TriReme Medical and a pair of related companies in favor of AngioScore, sending the case back to a lower court […]
TriReme, founder win AngioScore patent spat, lose bid for legal fees
AngioScore lost the patent infringement portion of its legal war with co-founder and former board member Eitan Konstantino, but won’t have to pay its opponents’ $4.8 million legal tab, a federal judge ruled this week. AngioScore, which accused Konstantino of violating his fiduciary duties when he started TriReme Medical, Quattro Vascular and QT Vascular, won a $20 million […]
QT Vascular wins stay in $20m loss to AngioScore
QT Vascular and a pair of related companies last week won a stay in their $20 million loss to AngioScore so their appeal can proceed. In July, a federal judge ruled that founder Eitan Konstantino violated his duties to AngioScore when he started QT Vascular, TriReme Medical and Quattro Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for $230 million, accused Konstantino of breaching his fiduciary duties […]
TriReme appeals $20m loss to AngioScore
TriReme Medical and a pair of related companies are appealing a $20 million loss to AngioScore after a federal judge ruled that founder Eitan Konstantino violated his duties to AngioScore when he started TriReme, Quattro Vascular and QT Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for $230 million, accused Konstantino of breaching his fiduciary duties to AngioScore by developing the TriReme’s Chocolate balloon catheter, […]
QT Vascular claims victory in patent spat with Spectranetics
QT Vascular said it prevailed in a court case brought against it by Spectranetics (NSDQ:SPNC) subsidiary Angioscore over patent infringement issues with QT Vascular’s Chocolate PTA balloon catheter. After a 7-day jury trial in the U.S. District Court for the Northern District of California, the jury ruled that QT Vascular’s Chocolate catheter did not infringe on […]
QT Vascular wins CE Mark for drug-coated balloon
QT Vascular said Monday it won CE Mark approval in the European Union for its Chocolate Touch drug-coated balloon for treating vascular disease. The device is a paclitaxel coated balloon meant to treat occluded arteries and mechanically dilate them with a balloon catheter, the company said. Singapore-based medical company said it expects a commercial launch of […]
UPDATE: Spectranetics’ AngioScore wins $20m from Trireme, founder Konstantino
UDATED July 8, 2015, with comment from QT Vascular, stock performance. AngioScore last week won a $20 million judgment against co-founder and former board member Eitan Konstantino, after a federal judge ruled that Konstantino violated his duties to AngioScore when he started TriReme Medical, Quattro Vascular and QT Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for […]